Detailed Information on Publication Record
2018
ClinVar database of global familial hypercholesterolemia-associated DNA variants
IACOCCA, M.A., J.R. CHORA, A. CARRIE, Tomáš FREIBERGER, S.E. LEIGH et. al.Basic information
Original name
ClinVar database of global familial hypercholesterolemia-associated DNA variants
Authors
IACOCCA, M.A. (124 Canada), J.R. CHORA (620 Portugal), A. CARRIE (250 France), Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), S.E. LEIGH (826 United Kingdom of Great Britain and Northern Ireland), J.C. DEFESCHE (528 Netherlands), C.L. KURTZ (840 United States of America), M.T. DISTEFANO (826 United Kingdom of Great Britain and Northern Ireland), R.D. SANTOS (76 Brazil), S.E. HUMPHRIES (826 United Kingdom of Great Britain and Northern Ireland), P. MATA (724 Spain), C.E. JANNES (76 Brazil), A.J. HOOPER (36 Australia), K.A. WILEMON (840 United States of America), P. BENLIAN (250 France), R. O CONNOR (840 United States of America), J. GARCIA (840 United States of America), H. WAND (840 United States of America), Lukáš TICHÝ (203 Czech Republic), E.J. SIJBRANDS (528 Netherlands), R.A. HEGELE (124 Canada), M. BOURBON (620 Portugal, guarantor) and J.W. KNOWLES (840 United States of America)
Edition
Human Mutation, New York, Wiley-Liss, 2018, 1059-7794
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10603 Genetics and heredity
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 4.453
RIV identification code
RIV/00216224:14110/18:00105335
Organization unit
Faculty of Medicine
UT WoS
000447138900016
Keywords in English
Clinical Genome Resource; ClinVar; familial hypercholesterolemia; variant interpretation
Tags
International impact, Reviewed
Změněno: 11/3/2019 15:49, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Accurate and consistent variant classification is imperative for incorporation of rapidly developing sequencing technologies into genomic medicine for improved patient care. An essential requirement for achieving standardized and reliable variant interpretation is data sharing, facilitated by a centralized open-source database. Familial hypercholesterolemia (FH) is an exemplar of the utility of such a resource: it has a high incidence, a favorable prognosis with early intervention and treatment, and cascade screening can be offered to families if a causative variant is identified. ClinVar, an NCBI-funded resource, has become the primary repository for clinically relevant variants in Mendelian disease, including FH. Here, we present the concerted efforts made by the Clinical Genome Resource, through the FH Variant Curation Expert Panel and global FH community, to increase submission of FH-associated variants into ClinVar. Variant-level data was categorized by submitter, variant characteristics, classification method, and available supporting data. To further reform interpretation of FH-associated variants, areas for improvement in variant submissions were identified; these include a need for more detailed submissions and submission of supporting variant-level data, both retrospectively and prospectively. Collaborating to provide thorough, reliable evidence-based variant interpretation will ultimately improve the care of FH patients.